Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07210892 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Paramedian Incidence Angles in Spinal Anaesthesia

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 30, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Site details revised
    • Collaborators: 1 to 2
    v3
  2. Minor Secondary endpoints: details revised at 1 of 1 entryv2 Show 4 more changesShow less
    • Study description expanded, about 33 words
    • Collaborators: 2 to 1
    • Publications: 2 to 4
    • Study title revised
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective here is to quantify the number of punctures and redirections during routine practice in the anesthesiology department, verify the final angle of incidence and the sac-skin distance by ultrasound, and determine the optimal, maximum, and minimum angles that would have allowed successful punctures. The objective is also to correlate ultrasound and plain X-ray distances, if available. These angles would then be inferred in advance in patients who must undergo spinal anesthesia, assessing whether this prior estimate reduces the number of punctures and redirections.
Trial Details
NCT Number NCT07210892
Lead Sponsor Consorci Sanitari de Terrassa
Collaborators: University of Barcelona, Hospital Clinic of Barcelona
Conditions
(from sponsor)
Anesthesia; Adverse Effect, Spinal and Epidural
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov